Cargando…
Guillain-Barre Syndrome, Facial Diplegia, and Pfizer COVID-19 Vaccine
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554006/ https://www.ncbi.nlm.nih.gov/pubmed/35065856 http://dx.doi.org/10.1016/j.jemermed.2021.10.038 |
Ejemplares similares
-
Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection
por: Chan, Jason L., et al.
Publicado: (2020) -
Facial Diplegia: A Rare Subtype of Guillain-Barré Syndrome in a Patient With Minimally Symptomatic COVID-19
por: Yang, Hwa Been, et al.
Publicado: (2021) -
Absence of proximal muscle weakness, dysarthria, and facial diplegia suggests Guillain–Barre syndrome rather than CIDP
por: Finsterer, Josef
Publicado: (2022) -
Guillain‐Barré syndrome presenting with facial diplegia following COVID‐19 vaccination in two patients
por: Kanabar, Gorande, et al.
Publicado: (2021) -
Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report
por: Rossetti, Arianna, et al.
Publicado: (2021)